79 related articles for article (PubMed ID: 17153514)
21. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
Litwin AH; Soloway I; Gourevitch MN
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
[TBL] [Abstract][Full Text] [Related]
22. Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.
Hagan H; Strauss SM; Astone JM; Des Jarlais DC
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S297-303. PubMed ID: 15768338
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C knowledge among primary care residents: is our teaching adequate for the times?
Coppola AG; Karakousis PC; Metz DC; Go MF; Mhokashi M; Howden CW; Raufman JP; Sharma VK
Am J Gastroenterol; 2004 Sep; 99(9):1720-5. PubMed ID: 15330909
[TBL] [Abstract][Full Text] [Related]
24. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
Treloar C; Newland J; Rance J; Hopwood M
J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
[TBL] [Abstract][Full Text] [Related]
25. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
Treloar C; Rance J;
Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
[TBL] [Abstract][Full Text] [Related]
26. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
27. A nationwide survey of hepatitis C services provided by drug treatment programs.
Strauss SM; Falkin GP; Vassilev Z; Des Jarlais DC; Astone J
J Subst Abuse Treat; 2002 Mar; 22(2):55-62. PubMed ID: 11932130
[TBL] [Abstract][Full Text] [Related]
28. The level of knowledge of, attitude toward and emphasis given to HBV and HCV infections among healthcare professionals: data from a tertiary hospital in Turkey.
Cekin AH; Cekin Y; Ozdemir A
Int J Occup Med Environ Health; 2013 Mar; 26(1):122-31. PubMed ID: 23532821
[TBL] [Abstract][Full Text] [Related]
29. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
Rose G; Cama E; Brener L; Treloar C
Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
[TBL] [Abstract][Full Text] [Related]
30. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
31. HIV screening and counseling for intravenous drug abuse patients. Staff and patient attitudes.
Curtis JL; Crummey FC; Baker SN; Foster RE; Khanyile CS; Wilkins R
JAMA; 1989 Jan; 261(2):258-62. PubMed ID: 2909023
[TBL] [Abstract][Full Text] [Related]
32. Addiction treatment staff perceptions of training as a facilitator or barrier to implementing evidence-based practices: a national qualitative research study.
D'Ippolito M; Lundgren L; Amodeo M; Beltrame C; Lim L; Chassler D
Subst Abus; 2015; 36(1):42-50. PubMed ID: 24965059
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.
Treloar C; Rance J; Bath N; Everingham H; Micallef M; Day C; Hazelwood S; Grebely J; Dore GJ
Int J Drug Policy; 2015 Oct; 26(10):992-8. PubMed ID: 25697089
[TBL] [Abstract][Full Text] [Related]
34. Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment.
Brener L; Treloar CJ
Aust Health Rev; 2009 Feb; 33(1):100-6. PubMed ID: 19203339
[TBL] [Abstract][Full Text] [Related]
35. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group.
Woolhouse S; Cooper E; Pickard A
Int J Drug Policy; 2013 Nov; 24(6):550-7. PubMed ID: 23860471
[TBL] [Abstract][Full Text] [Related]
36. HIV and hepatitis C knowledge among individuals with serious mental illness.
Goldberg RW; Tapscott SL; Calmes CA; Wolfe RS
Psychiatr Rehabil J; 2009; 33(1):47-9. PubMed ID: 19592379
[TBL] [Abstract][Full Text] [Related]
37. Knowledge of Case Workers and Correctional Officers towards HIV and HCV Infections: Opportunity for Public Health Education in the Correctional System.
Pérez CM; del Carmen Santos M; Torres A; Grana C; Albizu-García C
P R Health Sci J; 2015 Sep; 34(3):135-41. PubMed ID: 26356737
[TBL] [Abstract][Full Text] [Related]
38. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
[TBL] [Abstract][Full Text] [Related]
39. The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment.
Gilbert L; El-Bassel N; Rajah V; Foleno A; Fontdevila J; Frye V; Richman BL
Mt Sinai J Med; 2000; 67(5-6):452-64. PubMed ID: 11064497
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Doab A; Treloar C; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
